BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27696662)

  • 1. Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.
    Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJ; Møldrup U; Krag SP; Bibby BM; Birn H; Jespersen B
    Am J Transplant; 2017 Apr; 17(4):1042-1049. PubMed ID: 27696662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT).
    Krogstrup NV; Oltean M; Bibby BM; Nieuwenhuijs-Moeke GJ; Dor FJ; Birn H; Jespersen B
    BMJ Open; 2015 Aug; 5(8):e007941. PubMed ID: 26297360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote ischaemic conditioning and early changes in plasma creatinine as markers of one year kidney graft function-A follow-up of the CONTEXT study.
    Nielsen MB; Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJMF; Birn H; Jespersen B
    PLoS One; 2019; 14(12):e0226882. PubMed ID: 31887168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial.
    Wu J; Feng X; Huang H; Shou Z; Zhang X; Wang R; Chen Y; Chen J
    J Surg Res; 2014 May; 188(1):303-8. PubMed ID: 24556231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischemic conditioning may improve graft function following kidney transplantation: a systematic review and meta-analysis with trial sequential analysis.
    Zhang Y; Long Y; Li Y; Liao D; Hu L; Peng K; Liu H; Ji F; Shan X
    BMC Anesthesiol; 2024 May; 24(1):168. PubMed ID: 38702625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
    Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
    Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials.
    Schröppel B; Akalin E; Baweja M; Bloom RD; Florman S; Goldstein M; Haydel B; Hricik DE; Kulkarni S; Levine M; Mehrotra A; Patel A; Poggio ED; Ratner L; Shapiro R; Heeger PS
    Am J Transplant; 2020 Feb; 20(2):564-572. PubMed ID: 31452319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemia-Reperfusion in transplantation (REPAIR) randomised trial.
    Veighey KV; Nicholas JM; Clayton T; Knight R; Robertson S; Dalton N; Harber M; Watson CJE; De Fijter JW; Loukogeorgakis S; MacAllister R
    Br J Anaesth; 2019 Nov; 123(5):584-591. PubMed ID: 31521337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote ischemic preconditioning of transplant recipients to reduce graft ischemia and reperfusion injuries: A systematic review.
    Farooqui W; Pommergaard HC; Rasmussen A
    Transplant Rev (Orlando); 2018 Jan; 32(1):10-15. PubMed ID: 28637593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.
    Schnuelle P; Gottmann U; Hoeger S; Boesebeck D; Lauchart W; Weiss C; Fischereder M; Jauch KW; Heemann U; Zeier M; Hugo C; Pisarski P; Krämer BK; Lopau K; Rahmel A; Benck U; Birck R; Yard BA
    JAMA; 2009 Sep; 302(10):1067-75. PubMed ID: 19738091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Clinical Utility of Remote Ischemic Conditioning in Renal Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Zhou CC; Ge YZ; Yao WT; Wu R; Xin H; Lu TZ; Li MH; Song KW; Wang M; Zhu YP; Zhu M; Geng LG; Gao XF; Zhou LH; Zhang SL; Zhu JG; Jia RP
    PLoS One; 2017; 12(1):e0170729. PubMed ID: 28129389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
    Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
    Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed graft function in the kidney transplant.
    Siedlecki A; Irish W; Brennan DC
    Am J Transplant; 2011 Nov; 11(11):2279-96. PubMed ID: 21929642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function.
    Yu ZX; Qi S; Lasaro MA; Bouchard K; Dow C; Moore K; Wu Z; Barama A; Xu J; Johnson K; Marozsan AJ; Wang Y
    Am J Transplant; 2016 Sep; 16(9):2589-97. PubMed ID: 27003920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.
    Tingle SJ; Figueiredo RS; Moir JA; Goodfellow M; Talbot D; Wilson CH
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011671. PubMed ID: 30875082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular Mediators.
    Kierulf-Lassen C; Kristensen ML; Birn H; Jespersen B; Nørregaard R
    PLoS One; 2015; 10(12):e0146109. PubMed ID: 26720280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does liver ischemic preconditioning in brain death donors induce kidney preconditioning? A retrospective analysis.
    Desai KK; Mora-Esteves C; Holland BK; Dikdan G; Fisher A; Wilson DJ; Koneru B
    Transplantation; 2014 Feb; 97(3):337-43. PubMed ID: 24169340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.